DBC provides neural probes and cloud-based software to enable groundbreaking research and analysis of deep brain activity. With hundreds of customers globally, DBC’s devices are being used to help find therapies, and hopefully one day cures, for Parkinson’s, epilepsy, schizophrenia, depression, OCD, and more.
The medtech company was founded by Brian Jamieson based on his doctoral thesis on active neural probes. DBC manufactures a variety of neurological devices that can measure electrical activity in the brain, with its four categories being silicon, deep array, micro EcOG, and janus double-sided.
Each probe is created for different situations. The deep array probe is what DBC is most excited about, created with a specific plastic that is flexible enough to not break—it can go deep into the brain structures, such as the back of the brain, which is the root location of many disorders.
READ FULL ARTICLE HERE
